Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Selexipag

Catalog No. 335150
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Selective prostacyclin IP1 receptor agonist

6243Selective prostacyclin IP1 receptor agonist (Ki values are 260 and 2100 nM and for human and rat IP receptors, and >10 μM for EP1-4, DP, FP, and TP receptors). Prodrug for the active form of MRE 269. Ameliorates vascular endothelial dysfunction and increases femoral skin blood flow in rats. Orally available.

Chemical Identifiers

CAS 475086-01-2
Molecular Formula C26H32N4O4S
Molecular Weight (g/mol) 496.63
MDL Number MFCD10567093
InChI Key QXWZQTURMXZVHJ-UHFFFAOYSA-N
Synonym selexipag, uptravi, unii-5exc0e384l, 2-4-5,6-diphenylpyrazin-2-yl isopropyl amino butoxy-n-methylsulfonyl acetamide, 2-4-5,6-diphenylpyrazin-2-yl propan-2-yl amino butoxy-n-methanesulfonyl acetamide, 2-4-n-5,6-diphenylpyrazin-2-yl-n-isopropylamino butyloxy-n-methylsulfonyl acetamide, selexipag usan:inn, uptravi tn, ns-304 selexipag
PubChem CID 9913767
IUPAC Name 2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-methanesulfonylacetamide
SMILES CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=CN=C(C2=CC=CC=C2)C(=N1)C1=CC=CC=C1

Specifications

Quantity 50 mg
Formula Weight 496.62
Percent Purity >98%
Chemical Name or Material NS 304
Recommended Storage Store at -20°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.